ArticleInternational journal of clinical oncology2023

Efficacy and safety of nivolumab with ipilimumab for recurrent malignant pleural mesothelioma after primary surgical intervention.

Akifumi Nakamura et al.PubMed ↗Publisher ↗

No numbers read from the abstract.